Article History
Received: 8 October 2024
Accepted: 22 May 2025
First Online: 8 July 2025
Declarations
:
: Approval for this study was provided by the Melbourne Health Health Research Ethics Committee (QA2022_044).
: A/Prof Sheena Sullivan reports advisory board participation and consulting for Novavax, CSL Seqirus, Pfizer, Moderna and Evo Health. These are not believed to be relevant to this study as the above interests are in the field on influenza research.